The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea

NCT02750189 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 390

Last updated 2017-07-21

No results posted yet for this study

Summary

The purpose of this study is to estimate a direct/indirect medical cost and to provide evidence establishing efficient strategies to reduce medical costs of COPD in Korea.

Conditions

Interventions

OTHER

Direct cost

Money spent to treat COPD in medical institute based on HIRA

OTHER

Indirect cost

extra-expanses excluding hospital fees

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY
  • Konkuk University Medical Center

    lead OTHER

Principal Investigators

  • Kwang-Ha NA Yoo, Doctor · Konkuk University Hospial

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • South Korea

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02750189 on ClinicalTrials.gov